Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review

Only about 50% of patients with treatment-resistant schizophrenia respond to clozapine, and many more patients continue to experience ongoing and prominent negative symptoms. These negative symptoms, for which there are limited pharmacological options, may represent the greatest barrier to functiona...

Descripción completa

Detalles Bibliográficos
Autores principales: Oloyede, Ebenezer, Clark, Ivana, Mace, Shubhra, Whiskey, Eromona, Taylor, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801710/
https://www.ncbi.nlm.nih.gov/pubmed/35111297
http://dx.doi.org/10.1177/20451253211066642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801710/
https://www.ncbi.nlm.nih.gov/pubmed/35111297
http://dx.doi.org/10.1177/20451253211066642

Ejemplares similares